TeleCaRe: Expanding delivery of Cancer Rehabilitation via telehealth

Not Applicable

Recruiting

• Conditions: cancer; Cancer - Any cancer

• Registration Number: ACTRN12621001417875
• Lead Sponsor: Eastern Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-10-21
• Last Update Posted: 20 March 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 116

Inclusion Criteria

•Are aged 18 years and over.
•Have a cancer diagnosis.
•Living independently in the community (i.e. not a current inpatient or residential aged care resident)
•Are receiving cancer treatment (palliative or curative intent) or are within 12 months of completing adjuvant therapy (except for long term oral hormonal therapies).
•Have an Australian Karnofsky Performance Status score of equal to or greater than 60.
•Can speak conversational English.
•Have access to and are willing to use internet.
•Are able to give written informed consent

Exclusion Criteria

•They are deemed unsafe to exercise. A physiotherapist will screen for absolute exercise contra-indications in the medical record: unstable angina/hypertension/heart failure, arrhythmia, acute embolus/infarct, acute systemic infection with fever, dissecting aneurysm, acute myocarditis or pericarditis. The physiotherapist will obtain physician clearance to exercise if patient’s bloods and vital signs fall outside acceptable values. If patients have a medical condition that contraindicates participation in an exercise-based rehabilitation program as assessed by a physiotherapist or medical practitioner, they will be excluded.
•They have an Australian-modified Karnofsky Performance status of <60.
•They are an inpatient or residing in aged care.
•They have a cognitive impairment that precludes their ability to provide written, informed consent as assessed by their treating clinician.
•They are a high falls risk as determined by their treating clinician and/or FROP-COM screening score >4

Change made prior to enrolment commencement

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Health-related Quality of life measured by European Organization for Research and Treatment of Cancer QoL Questionnaire-C30 (EORTC-QLQ C30)[Post-intervention: Baseline, immediately post-intervention: week 9 (primary end point), 4-months post intervention completion]